Moderna, JFrog, TransMedics, Ubiquiti And Other Big Stocks Moving Higher On Friday
U.S. stocks rose, Nasdaq gained ~400 points. Moderna jumped 9.1% on strong Q3 results and higher FY26 guidance; other stocks rallied on results and deals.
Stocks · News reference
Why Is Oklo Stock Gaining Friday?
Oklo stock rises after Q3 revenue beats estimates, Aurora reactor construction advances and a new manufacturing deal supports expansion.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Oklo Publishes Third Quarter 2026 Financial Results and Business Update
Oklo Inc. released its financial results for the third quarter ended September 30, 2026, and provided a business update on its advanced nuclear technology projects.
Enbridge, Moderna On Deck Friday As Demand, Vaccine Pipeline Face Test
Enbridge headlines Friday’s reports, with investors weighing whether resilient pipeline utilization can offset a softer revenue comparison. Moderna, Brookfield Asset Management, Humana, Vistra, PPL, Plains All American
Better Nuclear Energy Stock to Buy After the Sell-Off: Oklo vs. BWX Technologies
Nuclear energy stocks have experienced significant sell-offs in 2026, with Oklo down 86% and BWX Technologies down 45% from their highs. The article compares the two companies, concluding that BWX Technologies is the better buy due to its established military contracts, diversified revenue streams, and commercial opportunities in small modular reactors. Oklo, while promising, remains pre-revenue with no NRC-approved reactor design and is years away from operations.
The Zacks Analyst Blog Highlights Oklo, Talen Energy and NuScale Power
Zacks analysts discuss three advanced nuclear energy companies ahead of earnings. Oklo Inc. is set to report Q3 2026 results with expected $2.2M in revenue but continued losses. The analysis highlights long-term growth potential from Aurora projects and supply chain expansion, but warns of near-term challenges including rising expenses, higher capital spending, and a history of earnings misses. Investors are cautioned to consider reducing exposure rather than initiating new positions.
Wedbush Initiates Coverage on Oklo with Outperform Rating
Wedbush has initiated coverage on Oklo Inc. with an 'Outperform' rating and a $36 price target, citing the company's potential to benefit from rising electricity demand driven by AI infrastructure.